Drug intelligence / Profile preview

Inkure

Development stage: Preclinical
Lead developer: Kure Cells
Modality: Hydrogel Systems → Drug Delivery Systems
Administration: Arthroscopic

Overview

Inkure is a chondroinductive bio-ink developed by Cells for Cells for the treatment of knee cartilage injuries and articular cartilage lesions. It is designed to be delivered via a specialized arthroscopic medical device. The bio-ink acts as a regenerative scaffold that induces the formation of new cartilage at the site of the lesion, facilitating tissue repair. This approach combines the properties of a regenerative material with a minimally invasive delivery system to address osteoarticular damage.

Brand names: Inkure

Beyond the preview

Go deeper on Inkure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inkure.

Explore the full profile